Koyfin Home > Directory > Health Care > Horizon Therapeutics > Total Debt / Capital

Horizon Therapeutics Total Debt / Capital Chart (HZNP)

Horizon Therapeutics annual/quarterly Total Debt / Capital from 2010 to 2020.
  • Horizon Therapeutics Total Debt / Capital for the quarter ending September 09, 2020 was $22m a -80.39% decrease of -17m year over year
  • Horizon Therapeutics Total Debt / Capital for the last 12 months ending September 09, 2020 was $22m a -80.39% decrease of -17m year over year
  • Horizon Therapeutics Annual Total Debt / Capital for 2019 was $39m a -57.11% decrease of -22m from 2018
  • Horizon Therapeutics Annual Total Debt / Capital for 2018 was $61m a -6.61% decrease of -4m from 2017
  • Horizon Therapeutics Annual Total Debt / Capital for 2017 was $66m a 10.16% increase of 7m from 2016
Other Ratios Metrics:
  • Horizon Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $434m a -18.99% decrease of -82m year over year
  • Horizon Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $180m a -22.96% decrease of -41m year over year
View Chart On Koyfin

Quarterly HZNP Total Debt / Capital Data

09/2020$22m
06/2020$34m
03/2020$39m
12/2019$39m
09/2019$47m
06/2019$48m
03/2019$52m
12/2018$61m
09/2018$67m
06/2018$69m

Annual HZNP Total Debt / Capital Data

2019$39m
2018$61m
2017$66m
2016$59m
2015$46m
2014$39m
2013$180m
2012$32m
2011$30m
2010$20m